Skip to main navigation Skip to search Skip to main content

Assessment of changes in immune measures of multiple sclerosis patients treated with laquinimod

  • Brett T. Lund*
  • , Eve E. Kelland
  • , Liat Hayardeny
  • , Oren Barilan
  • , Wendy Gilmore
  • , Leslie P. Weiner
  • *Corresponding author for this work
  • University of Southern California
  • Teva Pharmaceutical Industries Ltd.

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)108-115
Number of pages0
JournalJournal of Neuroimmunology
Volume263
Issue number0
DOIs
Publication statusPublished - Oct 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this